ReviewBone marrow transplantation2025

Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice.

Brian C Shaffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.